Reigns: The Witcher is the newest entry in the Reigns series and seeks to bring the world of the Witcher to life in a new way ...
Vice President, Investor Relations at Ascendis Pharma A/S. Joining me on the call today are Jan Moller Mikkelsen, President ...
This afternoon, we released financial results for the quarter and full year ended December 31, 2025, and recent corporate updates. The press release is available on the Investors section of our ...
Improving recognition and outcomes in pelvic venous disease through embolization, with case examples. Gloria Salazar, MD, ...
Sarepta Therapeutics, Inc. ( SRPT) Q4 2025 Earnings Call February 25, 2026 4:30 PM EST ...
Multiplier tasks involve activities humans can already perform but accelerate with AI, such as summarization or translation. Enabler tasks allow previously inaccessible creative production, such as ...
Klotho Neurosciences, Inc. (NASDAQ:KLTO) announced the launch of a new genomics diagnostics initiative centered on two epigenetics-based tests designed to support its clinical trials and expand ...
Updated ACVIM guidance prioritizes therapeutic diets and microbiome-directed therapy, identifying Visbiome Vet as the only probiotic currently backed by randomized clinical trial data for CIE.
A panel of physicians, biotech leaders and patient advocates took aim at the FDA during a Senate hearing Thursday on how the ...
In 2025, we took several important steps to maximize LINZESS, advance aproglutide, and deliver sustained profits and cash flows to strengthen our financial position and position the company for ...